Pages that link to "Item:Q7809"
Jump to navigation
Jump to search
The following pages link to Table appearing in a publication (Q7809):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148) (Q7908) (← links)
- Table 2 - Examples of recombinant antigens and monoclonal antibodies expressed in plants (From DOI: 10.3390/pathogens9020148) (Q7909) (← links)
- Table 1 - Characteristics of Patients With Confirmed COVID-19 Included in This Analysis (n = 181)* (From DOI: 10.7326/m20-0504) (Q7928) (← links)
- Table 2 - Expected Number of Symptomatic SARS-CoV-2 Infections That Would Be Undetected During Active Monitoring, Given Varying Monitoring Durations and Risks for Symptomatic Infection After Exposure* (From DOI: 10.7326/m20-0504) (Q7929) (← links)
- Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8469) (← links)
- Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8470) (← links)
- Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8471) (← links)
- Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8472) (← links)
- Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) (Q8473) (← links)
- Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8474) (← links)
- Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8475) (← links)
- Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8476) (← links)
- Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8477) (← links)
- Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8479) (← links)
- Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8480) (← links)
- Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8481) (← links)
- Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8482) (← links)
- Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8483) (← links)
- Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8484) (← links)
- Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8485) (← links)